Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia
Top Cited Papers
- 1 October 2009
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (11) , 3487-3496
- https://doi.org/10.1172/jci39482
Abstract
Arteriovenous malformations (AVMs) are vascular anomalies where arteries and veins are directly connected through a complex, tangled web of abnormal arteries and veins instead of a normal capillary network. AVMs in the brain, lung, and visceral organs, including the liver and gastrointestinal tract, result in considerable morbidity and mortality. AVMs are the underlying cause of three major clinical symptoms of a genetic vascular dysplasia termed hereditary hemorrhagic telangiectasia (HHT), which is characterized by recurrent nosebleeds, mucocutaneous telangiectases, and visceral AVMs and caused by mutations in one of several genes, including activin receptor–like kinase 1 (ALK1). It remains unknown why and how selective blood vessels form AVMs, and there have been technical limitations to observing the initial stages of AVM formation. Here we present in vivo evidence that physiological or environmental factors such as wounds in addition to the genetic ablation are required for Alk1-deficient vessels to develop to AVMs in adult mice. Using the dorsal skinfold window chamber system, we have demonstrated for what we believe to be the first time the entire course of AVM formation in subdermal blood vessels by using intravital bright-field images, hyperspectral imaging, fluorescence recordings of direct arterial flow through the AV shunts, and vascular casting techniques. We believe our data provide novel insights into the pathogenetic mechanisms of HHT and potential therapeutic approaches.This publication has 45 references indexed in Scilit:
- Regulation of vascular morphogenesis by Notch signalingGenes & Development, 2007
- Novel Insights into Wound Healing Sequence of EventsToxicologic Pathology, 2007
- Notch signaling in vascular development and physiologyDevelopment, 2007
- Potential Solutions for Confocal Imaging of Living AnimalsBioTechniques, 2007
- Health‐Related Quality of Life in Hereditary Hemorrhagic TelangiectasiaOtolaryngology -- Head and Neck Surgery, 2007
- Septectomy and Septal Dermoplasty for the Treatment of Severe Transfusion-Dependent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia and Septal PerforationAmerican Journal of Rhinology, 2007
- BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesisJournal of Cell Science, 2007
- Multiphoton microscopy for blood vessel imaging: new non-invasive tools (Spectral, SHG, FLIM).2007
- Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease.2002
- Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)American Journal of Medical Genetics, 2000